Concepedia

Kathleen M. Ogilvie

KM

Statistics

Publications

26

Citations

1.4K

H-Index

21

Active since

1996

Affiliations

Salk Institute for Biological Studies(Current)

Ligand Pharmaceuticals (United States)

Pfizer (United States)

Clayton Foundation

Eli Lilly (United States)

Kathleen M. Ogilvie is an author at Salk Institute for Biological Studies specializing in endocrinology, medicine, and pharmacology.

Publications per year

1996–2025

26

Publications

26

Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody

Jie Huang, Tetsuya Ishino, Gang Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 118 citations

Life Sciences, Biochemistry, Biotechnology +17

Gender difference in hypothalamic–pituitary–adrenal axis response to alcohol in the rat: activational role of gonadal steroids

Kathleen M. Ogilvie, Catherine Rivier · Brain Research · 1997 · 118 citations

Medicine, Endocrinology, Neuroscience +15

Effect of Three Different Modes of Alcohol Administration on the Activity of the Rat Hypothalamic‐Pituitary‐Adrenal Axis

Kathleen M. Ogilvie, Soon Lee, Catherine Rivier · Alcoholism Clinical and Experimental Research · 1997 · 117 citations

Medicine, Endocrinology, Pharmacology +16

A Tailored Therapy for the Metabolic Syndrome

Garret J. Etgen, Brian A. Oldham, W. Thomas Johnson et al. · Diabetes · 2002 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Metabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity

Peter J. Davies, Stacey A. Berry, Gregory L. Shipley et al. · Molecular Pharmacology · 2001 · 89 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

1–5 of 26